Lamotrigine Tablet
Product Images NDC 80425-0289

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 80425-0289). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Description (Description)

Chemical structure diagram of lamotrigine showing its molecular connectivity, including chlorine atoms, nitrogen atoms, and amino groups.*

FDA Label Image

Fig 1 (Fig 1)

A Kaplan-Meier survival curve graph showing failure probability over weeks for Lamotrigine and Placebo groups. The Y-axis represents failure probability in percentage, and the X-axis represents time in weeks. The Lamotrigine curve indicates a generally lower failure probability compared to Placebo, with censored data points marked on both curves.*

FDA Label Image

Label 1 (Lamotrigine Tablet 80425 0289 01)

Label for Lamotrigine 25 mg tablets by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions, lot number and expiration date placeholders (Expires: 3/23/2023), barcode, and comparison reference to Lamictal NDC 00478-0111-01. The package size is indicated as #30 tablets.*

FDA Label Image

Label 2 (Lamotrigine Tablet 80425 0289 02)

Packaging label for Lamotrigine 25 mg oral tablets by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions (20°-25°C), a comparison to Lamictal, NDC number 80425-0289-02, lot number placeholder, and expiration date 3/23/2023. The package contains 60 tablets.*

FDA Label Image

Label 3 (Lamotrigine Tablet 80425 0289 03)

Lamotrigine 25 mg tablet packaging label from Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions, barcode, and lot/expiration date fields. It states to compare to Lamictal and lists the NDC as 80425-0289-03.*

FDA Label Image

Fig 2 (Fig 2)

A Kaplan-Meier failure probability plot comparing Lamotrigine and placebo over approximately 80 weeks. The y-axis represents failure probability (%) and the x-axis shows time in weeks. Two labeled curves indicate higher failure probability for placebo versus Lamotrigine. Censored data points are marked on the curves.*

FDA Label Image

Logo 3 (Logo 2)

Lamotrigine tablets in various strengths and colors as shown: 25 mg white tablet marked with 'U 111', 100 mg white tablet marked with 'U 112', 150 mg white tablet marked with 'U 113', and 200 mg light blue tablet marked with 'U 114'. Each tablet shape and imprint is distinctive for identification.*

FDA Label Image

Logo (Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.